Newsstand Menu

Home / Newsstand / CSHL Stories and Media

CSHL Stories and Media archive for Tag: cancer biology

Filter by tag

Vitamin B6, leukemia’s deadly addiction

1/13/2020

Acute Myeloid Leukemia is addicted to vitamin B6. Now that researchers know this, they can pursue new treatment options for the deadly blood cancer. Read the story »

Milestone reached in new leukemia drug

11/19/2019

Salt-Inducible Kinase 3 (SIK3) could be a good therapeutic candidate for treating MLL translocation positive subtype of leukemia. Read the story »

photo of William Kaelin Nobel Laureate Labdish

Nobel laureate William Kaelin draws a crowd

10/29/2019

Nobel laureate and cancer researcher William Kaelin holds a seminar on his award-winning research at CSHL. Read the story »

Photo of AML defective blood cells Krainer

Mutant cells team up to make an even deadlier blood cancer

10/2/2019

Two very different mutations have been identified as unexpected partners-in-crime for causing the deadly blood cancer acute myeloid leukemia. Read the story »

J Potter M Findley EC MacDowell M Taylor

How a lab and its model animals changed science

8/13/2019

The natural history of science at Cold Spring Harbor Laboratory through the lens of animal research. Read the story »

Cancer cells’ “self eating” may be new drug target

7/1/2019

Researchers reveal how pancreatic cancer cells adapt to the low energy environment of a tumor. Watch the video »

Cancer cell’s “self eating” tactic may be its weakness

7/1/2019

Pancreatic cancer cells are eating their own mitochondria to survive and spread. New research reveals how, hinting at a possible new drug target. Read the story »

Tuveson pancreatic immunofluorescence CA19-9

Sugars that coat proteins are a possible drug target for pancreatitis

6/20/2019

CA19-9, a complex sugar structure coating proteins, represents a possible drug target for treatment of pancreatitis and prevention of pancreatic cancer. Read the story »

Can these sugars serve as a possible drug target for pancreatitis?

6/20/2019

CSHL Tuveson lab member Dani Engle explains how sugars serve as a possible drug target for pancreatitis. Watch the video »

Special fibroblasts help pancreatic cancer cells evade immune detection

6/13/2019

Researchers found a specific type of cancer-associated fibroblast interacts with the immune system to help pancreatic cancer cells stay under the radar. Read the story »

One experiment: Observing cancer’s progress in a mouse prostate

3/14/2019

Using a technique originally designed for mapping brains, two CSHL labs have worked together to image cancer progression in a mouse prostate. Read the story »

Nation’s cancer centers endorse HPV vaccination

6/8/2018

Dr. Stillman and Dr. Tuveson joined with the leaders of other institutions nationwide in endorsing a statement regarding the HPV vaccine Read the story »

Hannon named director of Cancer Research UK Cambridge Institute

11/21/2017

Dr. Greg Hannon has been named the new director of the Cancer Research UK Cambridge Institute, effective February 1, 2018. Read the story »

Freeze-frames of enzymes in action have implications for a new cancer treatment concept

7/3/2017

TUTase enzymes interact with let-7, a regulator of development; targeting them could help control certain cancers. Read the story »

A protein that stem cells require could be a target in killing breast cancer cells

6/1/2017

Cancer cells, like stem cells, have the ability to multiply indefinitely but epigenetic factor BPTF may be a shared weakness. Read the story »